{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.Business"},"BusinessResponsibilities":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/BusinessResponsibilities"}},"RelatedBusinesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/RelatedBusinesses"}},"BusinessRoles":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/BusinessRoles"}},"Publications":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/Publications"}},"LegislativePeriods":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/LegislativePeriods"}},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/Sessions"}},"Preconsultations":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/Preconsultations"}},"Bills":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/Bills"}},"Councils":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/Councils"}},"BusinessTypes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/BusinessTypes"}},"Votes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/Votes"}},"SubjectsBusiness":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/SubjectsBusiness"}},"BusinessStates":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/BusinessStates"}},"Council":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/Council"}},"Transcripts":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20095285,Language='DE')/Transcripts"}},"ID":20095285,"Language":"DE","BusinessShortNumber":"09.5285","BusinessType":14,"BusinessTypeName":"Fragestunde. Frage","BusinessTypeAbbreviation":"Fra.","Title":"Die umstrittene HPV-Impfung gegen Geb\u00e4rmutterhalskrebs und die grosse finanzielle Belastung f\u00fcr die Grundversicherung der Krankenkassen","Description":null,"InitialSituation":null,"Proceedings":null,"DraftText":null,"SubmittedText":"<p>1. Stimmen die Informationen, wonach Langzeitstudien fehlen und deshalb die Impfung in Kanada und Australien nicht zugelassen ist?</p><p>2. Trifft es zu, dass verschiedentlich schwere Nebenwirkungen und sogar Todesf\u00e4lle zu verzeichnen sind?</p><p>3. Weiss der Bundesrat, dass die Schutzwirkung der HPV-Impfung lediglich bei 2 der 15 HPV-Typen existiert?</p><p>4. Wo ist das Kosten-Nutzen-Verh\u00e4ltnis?</p>","ReasonText":null,"DocumentationText":null,"MotionText":null,"FederalCouncilResponseText":null,"FederalCouncilProposal":null,"FederalCouncilProposalText":null,"FederalCouncilProposalDate":null,"SubmittedBy":"Geissb\u00fchler Andrea Martina","BusinessStatus":229,"BusinessStatusText":"Erledigt","BusinessStatusDate":"\/Date(1244419200000)\/","ResponsibleDepartment":4,"ResponsibleDepartmentName":"Departement des Innern","ResponsibleDepartmentAbbreviation":"EDI","IsLeadingDepartment":true,"Tags":"2841","Category":null,"Modified":"\/Date(1690486295733)\/","SubmissionDate":"\/Date(1244419200000)\/","SubmissionCouncil":1,"SubmissionCouncilName":"Nationalrat","SubmissionCouncilAbbreviation":"NR","SubmissionSession":4809,"SubmissionLegislativePeriod":48,"FirstCouncil1":null,"FirstCouncil1Name":null,"FirstCouncil1Abbreviation":null,"FirstCouncil2":null,"FirstCouncil2Name":null,"FirstCouncil2Abbreviation":null,"TagNames":"Gesundheit"}}